Citations

Showing 10 of 108162 citations.

Tissue Handling for Genome-Wide Expression Analysis: A Review of the Issues, Evidence, and Opportunities
Medeiros, Fabíola, Rigl, C. Ted, Anderson, Glenda G. , Becker, Shawn, Halling, Kevin C.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 12 | Pages: 1805-1816

10.5858/2007-131-1805-thfgea | PMID 18081440 Get It

Abstract Context. —Molecular diagnostic applications that use microarrays to analyze large numbers of genes simultaneously require high-quality mRNA. As these genome-wide expression assays become more commonly used in medical practice, pathologists and oncologists will benefit from understanding the importance of obtaining high-quality RNA in order to generate reliable diagnostic and prognostic information, especially as these relate to cancer. Objective. —To review the effects that different tissue preservation techniques have on RNA quality and to provide practical advice on changes in tissue acquisition and handling that may soon be needed for certain clinical situations. Data Sources. —A review of recent literature on RNA quality, tissue fixation, cancer diagnosis, and gene expression analysis. Conclusions. —Studies have consistently shown that frozen tissue yields more intact RNA than formalin-fixed, paraffin-embedded tissue. The chemical modification, cross-linking, and fragmentation caused by formalin fixation often render RNA unsuitable for microarray analysis. Thus, when expression analysis involving hundreds or more than 1000 gene markers is contemplated, pathologists should consider freezing a specimen within half an hour (preferably within minutes) of surgical resection and storing it at −80°C or below. In coming years, pathologists will need to work closely with oncologists and other clinicians to determine when saving frozen tissue for microarray expression analysis is both practical and necessary. In select cases, the benefit of implementing a few extra tissue-handling steps may improve diagnostic and prognostic capability.
Utility of Tissue-Specific Transcription Factors Thyroid Transcription Factor 1 and Cdx2 in Determining the Primary Site of Metastatic Adenocarcinomas to the Brain
Strickland-Marmol, Leah B., Khoór, András , Livingston, Sandra, Rojiani, Amyn M.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 11 | Pages: 1686-1690

10.5858/2007-131-1686-uottft | PMID 17979487 Get It

Abstract Context. —Brain metastases of adenocarcinoma of unknown primary pose a diagnostic dilemma to the surgical pathologist. Although the most common source in these cases is the lung, determining a primary source is difficult on routinely stained slides. Immunohistochemical stain panels including differential cytokeratins, hormone receptors, and breast-specific proteins are commonly used in these cases. Recently, attention has turned to tissue-specific transcription factors, such as thyroid transcription factor 1 (TTF-1) and Cdx2, in the appraisal of metastatic adenocarcinomas. Objective. —To characterize the previously unpublished immunohistochemical expression of the relatively new tissue-specific transcription factor Cdx2 in metastatic adenocarcinomas to the brain. Design. —We reviewed the surgical pathology files of the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla, and retrieved 38 consecutive cases of metastatic adenocarcinoma (22 pulmonary, 10 breast, 6 gastrointestinal [2 esophagus/gastroesophageal junction, 4 colorectal]) to the brain with confirmation of the primary site by chart review and histologic evaluation. Sections were immunohistochemically stained with antibodies to TTF-1, Cdx2, and cytokeratins 7 and 20 by standard methods. Results. —Specificities and positive predictive values for Cdx2 and TTF-1 equaled 100% for metastatic gastrointestinal and pulmonary adenocarcinomas, respectively. The negative predictive value of Cdx2 was also very high at 97%. Conclusions. —Cdx2 is a specific and valuable tool for the surgical pathologist when faced with the common problem of metastatic adenocarcinoma of unknown primary. In conjunction with TTF-1, cytokeratin 7, and cytokeratin 20, Cdx2 can accurately differentiate the most common sources of metastatic adenocarcinoma to the brain.
Site-Specific Morphologic Differences in Extranodal Marginal Zone B-Cell Lymphomas
Rawal, Ajay, Finn, William G., Schnitzer, Bertram, Valdez, Riccardo

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 11 | Pages: 1673-1678

10.5858/2007-131-1673-smdiem | PMID 17979485 Get It

Abstract Context. —Lymphoepithelial lesions (LELs) are a useful diagnostic feature of extranodal marginal zone B-cell lymphoma (EMZL); however, there is scant literature comparing their frequency and morphology at various sites. Objective. —To evaluate any diagnostically useful, site-specific, morphologic patterns in EMZLs. Design. —In this retrospective review, we evaluated 136 EMZLs from different sites for LEL pattern and other pathologic differences, including CD43 coexpression and plasma cell component features. Results. —Prominent and destructive LELs were most common in salivary and thyroid gland cases, and LELs were rare to absent in breast, skin, and ocular adnexa cases. An LEL pattern with lymphocytes “stuffing” glandular lumina was seen in lung, thyroid, and salivary gland cases. Monoclonal plasma cells were most common in breast, upper aerodigestive tract, skin, and salivary gland cases. CD43 coexpression was seen in 36% of cases, most commonly in salivary gland, stomach, and upper aerodigestive tract. Conclusions. —The relative importance of LEL pattern, CD43 coexpression, and clonal plasma cell component in EMZLs is site-dependent, and the differences may aid in the diagnosis of EMZLs at different anatomic sites.
The miR–181a–SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovarian Cancer
Nagaraj, Anil Belur , Knarr, Matthew , Connor, R. Shae , Kovalenko, Olga , Fleming, Alexis , Surti, Arshia, Nurmemmedov, Elmar , Beltrame, Luca , Marchini, Sergio , Kahn, Michaël , DiFeo, Analisa , Belur Nagaraj, Anil, Connor, R Shae , Beltrame, Luca , Kahn, Michael , DiFeo, Analisa , Sekhar, Sreeja C. , Joseph, Peronne L.

Mayo Clinic

Cancer Research | February 11, 2021 | Volume: 81 | Issue: 8 | Pages: 2044-2055

10.1158/0008-5472.can-20-2041 | PMID 33574092 Get It

Abstract Wnt signaling is a major driver of stemness and chemoresistance in ovarian cancer, yet the genetic drivers that stimulate its expression remain largely unknown. Unlike other cancers, mutations in the Wnt pathway are not reported in high-grade serous ovarian cancer (HGSOC). Hence, a key challenge that must be addressed to develop effective targeted therapies is to identify nonmutational drivers of Wnt activation. Using an miRNA sensor-based approach, we have identified miR-181a as a novel driver of Wnt/β-catenin signaling. miR-181ahigh primary HGSOC cells exhibited increased Wnt/β-catenin signaling, which was associated with increased stem-cell frequency and platinum resistance. Consistent with these findings, inhibition of β-catenin decreased stem-like properties in miR-181ahigh cell populations and downregulated miR-181a. The Wnt inhibitor SFRP4 was identified as a novel target of miR-181a. Overall, our results demonstrate that miR-181a is a nonmutational activator of Wnt signaling that drives stemness and chemoresistance in HGSOC, suggesting that the miR–181a–SFRP4 axis can be evaluated as a novel biomarker for β-catenin–targeted therapy in this disease. Significance: These results demonstrate that miR-181a is an activator of Wnt signaling that drives stemness and chemoresistance in HGSOC and may be targeted therapeutically in recurrent disease.
Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3
Mocci, Evelina, Kundu, Prosenjit, Wheeler, William, Arslan, Alan A. , Beane-Freeman, Laura E., Bracci, Paige M., Brennan, Paul , Canzian, Federico , Du, Mengmeng, Gallinger, Steven, Goodman, Phyllis J., Kooperberg, Charles, Marchand, Loic Le, Neale, Rachel E., Shu, Xiao-Ou, Visvanathan, Kala , White, Emily, Zheng, Wei, Albanes, Demetrius, Andreotti, Gabriella, Babic, Ana, Berndt, Sonja I., Bueno-de-Mesquita, Bas, Buring, Julie E., Campa, Daniele, Chanock, Stephen J., Childs, Erica J., Fuchs, Charles S., Gaziano, J. Michael, Giovannucci, Edward L., Goggins, Michael G., Hartge, Patricia, Hassan, Manal M., Holly, Elizabeth A., Hoover, Robert N., Kurtz, Robert C., Lee, I-Min, Ng, Kimmie, Oberg, Ann L. , Panico, Salvatore, Peters, Ulrike, Porta, Miquel, Rabe, Kari G. , Riboli, Elio, Rothman, Nathaniel, Scelo, Ghislaine, Sesso, Howard D. , Silverman, Debra T., Stevens, Victoria L. , Strobel, Oliver , Thompson, Ian M., Tjønneland, Anne , Trichopoulou, Antonia, Wactawski‐Wende, Jean , Wentzensen, Nicolas, Wilkens, Lynne R., Yuan, Fangcheng , Zeleniuch-Jacquotte, Anne, Li, Donghui , Jacobs, Eric J., Petersen, Gloria M., Wolpin, Brian M., Risch, Harvey A., Kraft, Peter, Chatterjee, Nilanjan, Ríboli, Elio , Zeleniuch‐Jacquotte, Anne , Thompson, Ian M. , Mocci, Evelina , Porta, Miquel , Giles, Graham G , Visvanathan, Kala , Bamlet, William R , Blackford, Amanda , Duell, Eric J , Hung, Rayjean J , Malats, Nuria , Milne, Roger L , Oberg, Ann L , Chaffee, Kari G. , Sesso, Howard D , Stevens, Victoria L , Strobel, Oliver , Tjønneland, Anne , Van Den Eeden, Stephen K , Wactawski-Wende, Jean , Yu, Herbert , Yuan, Fangcheng , Amundadottir, Laufey , Li, Donghui , Klein, Alison P , Stolzenberg-Solomon, Rachael , Arslan, Alan A , Canzian, Federico , Riboli, Elio , Porta, Miquel , Thompson, Ian M , Zeleniuch-Jacquotte, Anne , Kundu, Prosenjit, Wheeler, William, Beane-Freeman, Laura E., Bracci, Paige M., Brennan, Paul , Du, Mengmeng, Gallinger, Steven, Goodman, Phyllis J., Kooperberg, Charles, Marchand, Loic Le, Neale, Rachel E., Shu, Xiao-Ou, White, Emily, Zheng, Wei, Albanes, Demetrius, Andreotti, Gabriella, Babic, Ana, Berndt, Sonja I., Bueno-de-Mesquita, Bas, Buring, Julie E., Campa, Daniele, Chanock, Stephen J., Childs, Erica J., Fuchs, Charles S., Gaziano, J. Michael, Giovannucci, Edward L., Goggins, Michael G., Hartge, Patricia, Hassan, Manal M., Holly, Elizabeth A., Hoover, Robert N., Kurtz, Robert C., Lee, I-Min, Ng, Kimmie, Panico, Salvatore, Peters, Ulrike, Rothman, Nathaniel, Scelo, Ghislaine, Silverman, Debra T., Thompson, Ian M., Trichopoulou, Antonia, Wentzensen, Nicolas, Wilkens, Lynne R., Jacobs, Eric J., Petersen, Gloria M., Wolpin, Brian M., Risch, Harvey A., Kraft, Peter, Chatterjee, Nilanjan

Mayo Clinic

Cancer Research | February 11, 2021 | Volume: 81 | Issue: 11 | Pages: 3134-3143

10.1158/0008-5472.can-20-3267 | PMID 33574088 Get It

Abstract Germline variation and smoking are independently associated with pancreatic ductal adenocarcinoma (PDAC). We conducted genome-wide smoking interaction analysis of PDAC using genotype data from four previous genome-wide association studies in individuals of European ancestry (7,937 cases and 11,774 controls). Examination of expression quantitative trait loci data from the Genotype-Tissue Expression Project followed by colocalization analysis was conducted to determine whether there was support for common SNP(s) underlying the observed associations. Statistical tests were two sided and P < 5 × 10–8 was considered statistically significant. Genome-wide significant evidence of qualitative interaction was identified on chr2q21.3 in intron 5 of the transmembrane protein 163 (TMEM163) and upstream of the cyclin T2 (CCNT2). The most significant SNP using the Empirical Bayes method, in this region that included 45 significantly associated SNPs, was rs1818613 [per allele OR in never smokers 0.87, 95% confidence interval (CI), 0.82–0.93; former smokers 1.00, 95% CI, 0.91–1.07; current smokers 1.25, 95% CI 1.12–1.40, Pinteraction = 3.08 × 10–9). Examination of the Genotype-Tissue Expression Project data demonstrated an expression quantitative trait locus in this region for TMEM163 and CCNT2 in several tissue types. Colocalization analysis supported a shared SNP, rs842357, in high linkage disequilibrium with rs1818613 (r2 = 0. 94) driving both the observed interaction and the expression quantitative trait loci signals. Future studies are needed to confirm and understand the differential biologic mechanisms by smoking status that contribute to our PDAC findings. Significance: This large genome-wide interaction study identifies a susceptibility locus on 2q21.3 that significantly modified PDAC risk by smoking status, providing insight into smoking-associated PDAC, with implications for prevention.
Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells
Ma, Tengjiao , Hu, Chengchen , Lal, Bachchu , Zhou, Weiqiang , Ma, Yongxin , Prinos, Panagiotis , Quiñones‐Hinojosa, Alfredo , Lim, Michael , Laterra, John , Li, Yunqing , Prinos, Panagiotis , Li, Yunqing , Zhou, Weiqiang , Ying, Mingyao

Mayo Clinic

Cancer Research | February 11, 2021 | Volume: 81 | Issue: 9 | Pages: 2457-2469

10.1158/0008-5472.can-20-2489 | PMID 33574085 Get It

Abstract A subset of stem-like cells in glioblastoma (GBM; GSC) underlies tumor propagation, therapeutic resistance, and tumor recurrence. Immune evasion is critical for GSCs to carry out these functions. However, the molecular mechanisms employed by GSCs to escape antitumor immunity remain largely unknown. The reprogramming transcription factors Oct4 and Sox2 function as core multipotency factors and play an essential role in the formation and maintenance of GSCs, but the roles of these transcription factors in GSC immune escape have not been well explored. Here we examine how Oct4/Sox2 coexpression contributes to the immunosuppressive phenotype of GSCs. Combined transcription profiling and functional studies of Oct4/Sox2 coexpressing GSCs and differentiated GBM cells demonstrated that Oct4 and Sox2 cooperatively induce an immunosuppressive transcriptome consisting of multiple immunosuppressive checkpoints (i.e., PD-L1, CD70, A2aR, TDO) and dysregulation of cytokines and chemokines that are associated with an immunosuppressive tumor microenvironment. Mechanistically, induction and function of BRD/H3k27Ac-dependent immunosuppressive genes played a role in the immunosuppressive phenotype of GSCs. Pan-BET bromodomain inhibitors (e.g., JQ1) and shBRD4 constructs significantly inhibited the immunosuppressive transcriptome and immunosuppressive biological responses induced by Oct4/Sox2. Our findings identify targetable mechanisms by which tumor-propagating GSCs contribute to the immunosuppressive microenvironment in GBM. Significance: This report identifies mechanisms by which the reprogramming transcription factors Oct4 and Sox2 function to drive the immunomodulatory transcriptome of GSCs and contribute to the immunosuppressive microenvironment in GBM.
Critical Leadership and Management Skills for Pathology Practice
Brimhall, Bradley B. , Wright, Louis D., McGregor, Kelli L., Hernandez, James S

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 10 | Pages: 1547-1554

10.5858/2007-131-1547-clamsf | PMID 17922591 Get It

Abstract Context.—Managed care has changed the nature of medical practice. The practice of pathology has also changed and is likely to undergo further modification. Additional skills in leadership and management are needed to perform optimally in the current medical marketplace. Objective.—To determine whether pathologists view business and informatics skills as being important and valuable in their practices. Design.—A survey was sent electronically (via e-mail) to 2566 pathologists and pathology administrators. Results.—Two hundred sixteen survey recipients (8.4%) responded to the survey. The response rate to individual questions ranged from 86% to 99% (186 to 214 of 216 total respondents). Most who took the survey ranked communication (203/209; 97%), leadership skills (165/209; 79%), and systems thinking skills (155/209; 74%) as either “very important” or “essential.” Fewer respondents were willing to offer salary premiums for marketing (108/196; 55%), business or finance (92/196; 47%), or staff leadership (95/196; 48%) skills unless the candidate had a track record of measurable achievement using these skills. Those practicing in academia as well as those making hiring decisions by themselves were more likely to value leadership and management skills. Fewer than 1% of respondents in any category considered current pathology residency training in leadership and management to be adequate. Conclusions.—Prospective employers value leadership and management skills. Pathology residency programs must include meaningful training in pathology practice management and informatics to satisfy the demand for these skills in the modern pathology marketplace.
Best Practices in Diagnostic Immunohistochemistry: Pleomorphic Cutaneous Spindle Cell Tumors
Folpe, Andrew L. , Cooper, Kumarasen

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 131 | Issue: 10 | Pages: 1517-1524

10.5858/2007-131-1517-bpidip | PMID 17922587 Get It

Abstract Context.—Pleomorphic cutaneous spindle cell tumors can be difficult to distinguish solely on histologic grounds. The use of ancillary immunohistochemical studies can greatly assist in this differential diagnosis. Objective.—To review histologic and immunohistochemical aspects of cutaneous spindle cell tumors and discuss a basic panel of markers to assist in the differential diagnosis. Data Sources.—English-language literature published between 1981 and 2005. Conclusions.—A basic immunohistochemistry panel for high-molecular-weight cytokeratin, melanocytic markers (S100 protein, HMB-45, Melan-A), smooth muscle actin, desmin, and endothelial markers (CD31, CD34) is effective in diagnosing most cutaneous spindle cell tumors.
mtor Haploinsufficiency Ameliorates Renal Cysts and Cilia Abnormality in Adult Zebrafish tmem67 Mutants
Zhu, Ping , Qiu, Qi , Harris, Peter C. , Harris, Peter C , Qiu, Qi, Xu, Xiaolei , Lin, Xueying

Mayo Clinic

Journal of the American Society of Nephrology | February 11, 2021 | Volume: 32 | Issue: 4 | Pages: 822-836

10.1681/asn.2020070991 | PMID 33574160 Get It

Significance Statement Zebrafish embryos are well recognized for their value in studying polycystic kidney disease, but they cannot fully recapitulate the pathogenesis of the disease. The establishment of tmem67 e3/e3 mutants provides the first adult zebrafish model for cystogenesis. The model exhibits progressive renal cysts and enables the discernment of compensational effects from pathogenic events. Development of a tissue-clearing, whole-mount imaging protocol allows the analysis of renal cysts and cilia abnormality at a single-nephron resolution. Evidence also indicates potential benefit of mammalian target of rapamycin inhibition in tmem67 -based cystogenesis. Combining powerful genetics and phenotyping tools, this novel adult zebrafish model shall facilitate mechanistic studies and therapeutic development for cystic diseases. Background Although zebrafish embryos have been used to study ciliogenesis and model polycystic kidney disease (PKD), adult zebrafish remain unexplored. Methods Transcription activator-like effector nucleases (TALEN) technology was used to generate mutant for tmem67 , the homolog of the mammalian causative gene for Meckel syndrome type 3 (MKS3). Classic 2D and optical-clearing 3D imaging of an isolated adult zebrafish kidney were used to examine cystic and ciliary phenotypes. A hypomorphic mtor strain or rapamycin was used to inhibit mTOR activity. Results Adult tmem67 zebrafish developed progressive mesonephric cysts that share conserved features of mammalian cystogenesis, including a switch of cyst origin with age and an increase in proliferation of cyst-lining epithelial cells. The mutants had shorter and fewer distal single cilia and greater numbers of multiciliated cells (MCCs). Absence of a single cilium preceded cystogenesis, and expansion of MCCs occurred after pronephric cyst formation and was inversely correlated with the severity of renal cysts in young adult zebrafish, suggesting a primary defect and an adaptive action, respectively. Finally, the mutants exhibited hyperactive mTOR signaling. mTOR inhibition ameliorated renal cysts in both the embryonic and adult zebrafish models; however, it only rescued ciliary abnormalities in the adult mutants. Conclusions Adult zebrafish tmem67 mutants offer a new vertebrate model for renal cystic diseases, in which cilia morphology can be analyzed at a single-nephron resolution and mTOR inhibition proves to be a candidate therapeutic strategy.
Histopathologic Findings of Malformations of Cortical Development in an Epilepsy Surgery Cohort
Morris, E. Brannon, Parisi, Joseph E. , Buchhalter, Jeffrey

Mayo Clinic

Archives of Pathology & Laboratory Medicine | February 11, 2021 | Volume: 130 | Issue: 8 | Pages: 1163-1168

10.5858/2006-130-1163-hfomoc | PMID 16879017 Get It

Abstract Context. —Malformations of cortical development (MCDs) are an important cause of pharmacoresistent epilepsy and are frequently diagnosed in surgical pathology. The lack of uniform tissue processing and standard histopathologic nomenclature to describe MCDs has resulted in diagnostic ambiguity. Objective. —To describe the immunohistochemical findings of MCDs from a relatively large surgical epilepsy cohort and incorporate terminology that more adequately reflects the histopathologic findings into a contemporary classification of MCD. Design. —Utilizing the Mayo Clinic Rochester Surgical Pathology Database and patient records, 53 patients with previous intractable epilepsy and a known malformation of cortical development were identified. All of the cohort's paraffin embedded surgical specimens were resectioned and stained with hematoxylin-eosin, Luxol fast blue/cresyl violet, neurofilament protein, and glial fibrillary acidic protein. Each specimen was reviewed histologically and categorized according to a proposed focal MCD classification scheme that substitutes cytoarchitectural dysmorphism for cortical dysplasia and architectural disorganization for microdysgenesis. Results. —An MCD was recognized in 49 patients and grouped into 1 of the following 4 categories: (1) cytoarchitectural dysmorphism with balloon cells (n = 19), (2) cytoarchitectural dysmorphism without balloon cells (n = 12), (3) architectural disorganization (n = 8), or (4) polymicrogyria (n = 9). Conclusions. —The histopathologic features of focal MCD in a large epilepsy surgical cohort by using practical immunohistochemistry and a contemporary MCD classification scheme are described. It is proposed that the term focal cortical dysplasia be renamed as focal malformations of cortical development.